Showing results (161-170 of 334) with videos related to
Sort By:
Pageof 34
Annals of Human Genetics|August 14, 2002
Genetic and environmental determinants of plasma high density lipoprotein cholesterol and apolipoprotein AI concentrations in healthy middle-aged menP J Talmud, E Hawe, K Robertson, et al.Journal of Medical Genetics|July 1, 1995
Utilities for high throughput use of the single strand conformational polymorphism method: screening of 791 patients with familial hypercholesterolaemia for mutations in exon 3 of the low density lipoprotein receptor geneR Whittall, V Gudnason, G P Weavind, et al.Heart (British Cardiac Society)|February 16, 2002
Impact of angiotensin converting enzyme inhibition on post-coronary artery bypass interleukin 6 releaseD J Brull, J Sanders, A Rumley, et al.Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|January 1, 1993
Identification of recurrent and novel mutations in exon 4 of the LDL receptor gene in patients with familial hypercholesterolemia in the United KingdomV Gudnason, L King-Underwood, M Seed, et al.Genetic Epidemiology|January 1, 1992
Estimation of the frequency of isoform-genotype discrepancies at the apolipoprotein E locus in heterozygotes for the isoformsF Mailly, P Moll, B A Kottke, et al.Journal of Lipid Research|June 5, 1999
Evidence for a third genetic locus causing familial hypercholesterolemia. A non-LDLR, non-APOB kindredL Haddad, I N Day, S Hunt, et al.Biochemical and Biophysical Research Communications|October 31, 1983
The isolation of a clone for human alpha 1-antitrypsin and the detection of alpha 1-antitrypsin in mRNA from liver and leukocytesJ Rogers, N Kalsheker, S Wallis, et al.Annals of Human Genetics|March 8, 2008
Update and analysis of the University College London low density lipoprotein receptor familial hypercholesterolemia databaseS E A Leigh, A H Foster, R A Whittall, et al.European Journal of Vascular Surgery|April 1, 1991
Genetic variants of collagen III and abdominal aortic aneurysmJ T Powell, J Adamson, S T MacSweeney, et al.Atherosclerosis|June 6, 2002
Genetic determinants of the response to bezafibrate treatment in the lower extremity arterial disease event reduction (LEADER) trialY Jamshidi, D M Flavell, E Hawe, et al.Pageof 34